Browse Pet Safety Reports
16,698 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,698 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,698 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| May 9, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Dispenser, Abnormal; Difficulty of Use; Tubes, Leaking; Application site skin... | Ongoing |
| May 8, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| May 7, 2018 | Human | Unknown | Selamectin | Facial rash (For urticaria see Immune SOC) | Outcome Unknown |
| May 7, 2018 | Human | Unknown | Imidacloprid; Moxidectin | Application site burning sensation; Application site tingling; Burning sensat... | Outcome Unknown |
| May 6, 2018 | Human | Unknown | Tulathromycin | Injection site reaction NOS | Outcome Unknown |
| May 6, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| May 5, 2018 | Human | Unknown | Florfenicol; Terbinafine; Betamethasone | Eye redness | Ongoing |
| May 4, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| May 4, 2018 | Human | Unknown | Doramectin | Injection site reaction NOS; Vertigo | Outcome Unknown |
| May 4, 2018 | Human | Unknown | Tulathromycin | Injection site reaction NOS | Outcome Unknown |
| May 4, 2018 | Human | Unknown | Spinosad; Milbemycin Oxime | Nausea; Increased sweating; Accidental exposure | Ongoing |
| May 4, 2018 | Human | Unknown | Selamectin | Headache; Tubes, Leaking; Odor, Abnormal | Recovered/Normal |
| May 4, 2018 | Human | Unknown | Tulathromycin | Injection site reaction NOS | Outcome Unknown |
| May 4, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| May 3, 2018 | Human | Unknown | Ceftiofur Crystalline Free Acid | Injection site swelling; Injection site pain; Injection site reaction NOS | Outcome Unknown |
| May 3, 2018 | Human | Unknown | Afoxolaner | Rash | Outcome Unknown |
| May 3, 2018 | Human | Unknown | Oxytetracycline | Injection site swelling; Injection site pain; Injection site reddening; Accid... | Recovered/Normal |
| May 3, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site burning sensation; Difficulty of Use; Dispenser, Abnormal; P... | Recovered/Normal |
| May 2, 2018 | Human | Unknown | Meloxicam | Death | Died |
| May 1, 2018 | Human | Unknown | Ractopamine | Cardiac disorder NOS | Outcome Unknown |
| Apr 30, 2018 | Human | Unknown | Cyclosporine | Nasal irritation; Burning sensation (skin) | Recovered/Normal |
| Apr 29, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Containers, Leaking; Dispenser, Abnormal; D... | Recovered/Normal |
| Apr 28, 2018 | Human | Unknown | Clomipramine | Throat irritation; Flatulence | Recovered/Normal |
| Apr 28, 2018 | Human | Unknown | Tulathromycin | Injection site reaction NOS; Unclassifiable adverse event; Injection site nodule | Outcome Unknown |
| Apr 28, 2018 | Human | Unknown | Fluralaner Chew Tablets | Swollen limb; Reddening of the skin; Generalised itching | Outcome Unknown |
| Apr 27, 2018 | Human | Unknown | Oclacitinib Maleate | Oedema NOS (see other SOCs for specific oedemas); Chest discomfort NOS; Diarr... | Ongoing |
| Apr 27, 2018 | Human | Unknown | Eprinomectin | Skin lesion NOS | Outcome Unknown |
| Apr 26, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Dispenser, Abnormal; Difficulty of Use | Recovered/Normal |
| Apr 25, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Dispenser, Abnormal; Difficulty of Use; Tub... | Ongoing |
| Apr 25, 2018 | Human | Unknown | Enrofloxacin | Injection site pain; Injection site bruising; Injection site swelling | Recovered/Normal |
| Apr 25, 2018 | Human | Unknown | Moxidectin | Eye pain; Dry eye | Recovered/Normal |
| Apr 24, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Numbness; Tingling sensation; Stomach pain; Dispenser, Abnormal; Difficulty o... | Recovered/Normal |
| Apr 24, 2018 | Human | Unknown | Fluralaner Chew Tablets | Burning sensation (skin); Reddening of the skin; Blistering (see also Applica... | Outcome Unknown |
| Apr 23, 2018 | Human | Unknown | Oclacitinib Maleate | Vomiting; Accidental exposure | Outcome Unknown |
| Apr 23, 2018 | Human | Unknown | Tilmicosin | Injection site pain; Accidental exposure | Recovered/Normal |
| Apr 22, 2018 | Human | Unknown | Grapiprant | Nausea; Accidental exposure | Ongoing |
| Apr 20, 2018 | Human | Unknown | Gamithromycin | Injection site bleeding | Recovered/Normal |
| Apr 20, 2018 | Human | Unknown | Florfenicol; Terbinafine Hydrochlorid... | Eye irritation; Eye stinging | Recovered/Normal |
| Apr 20, 2018 | Human | Unknown | Dinoprost Tromethamine | Bad taste | Outcome Unknown |
| Apr 20, 2018 | Human | Unknown | Praziquantel; Emodepside | Erythema (for urticaria see Immune SOC); Skin irritation | Outcome Unknown |
| Apr 19, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Apr 19, 2018 | Human | Unknown | Spinosad; Milbemycin Oxime | Cough; Lethargy (see also Central nervous system depression in 'Neurological') | Ongoing |
| Apr 19, 2018 | Human | Unknown | Moxidectin | Respiratory tract irritation; Accidental exposure | Recovered/Normal |
| Apr 18, 2018 | Human | Unknown | Florfenicol/Terbinafine Hydrochloride... | Eye irritation; Cloudy eye (for Miosis, Mydriasis, Anisocoria, Nystagmus - se... | Recovered/Normal |
| Apr 18, 2018 | Human | Unknown | Tulathromycin | Injection site reaction NOS; Injection site swelling | Outcome Unknown |
| Apr 14, 2018 | Human | Unknown | Tulathromycin | Injection site reaction NOS; Dizziness; Nausea | Recovered/Normal |
| Apr 13, 2018 | Human | Unknown | Tilmicosin | Injection site bleeding; Accidental exposure | Recovered/Normal |
| Apr 13, 2018 | Human | Unknown | Oxfendazole | General illness | Outcome Unknown |
| Apr 13, 2018 | Human | Unknown | Oxfendazole | Circulatory collapse (see also 'Neurological' and 'Systemic disorders'); Vomi... | Outcome Unknown |
| Apr 13, 2018 | Human | Unknown | Oclacitinib Maleate | Dry mouth; Accidental exposure | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.